ExodusPoint Capital Management LP Invests $646,000 in Clover Health Investments, Corp. (NASDAQ:CLOV)

ExodusPoint Capital Management LP purchased a new position in shares of Clover Health Investments, Corp. (NASDAQ:CLOV) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 204,952 shares of the company’s stock, valued at approximately $646,000.

Several other large investors also recently bought and sold shares of CLOV. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in shares of Clover Health Investments during the 3rd quarter worth approximately $1,228,000. Verition Fund Management LLC acquired a new position in Clover Health Investments during the third quarter worth $411,000. HighTower Advisors LLC acquired a new position in Clover Health Investments during the third quarter worth $97,000. Janus Henderson Group PLC purchased a new stake in Clover Health Investments in the 3rd quarter valued at $477,000. Finally, State Street Corp increased its stake in shares of Clover Health Investments by 65.0% in the 3rd quarter. State Street Corp now owns 2,189,380 shares of the company’s stock worth $6,174,000 after acquiring an additional 862,621 shares during the last quarter. Hedge funds and other institutional investors own 19.77% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. Canaccord Genuity Group upped their price objective on shares of Clover Health Investments from $4.20 to $4.50 and gave the company a “buy” rating in a report on Monday, March 3rd. Craig Hallum started coverage on shares of Clover Health Investments in a research note on Tuesday, December 17th. They issued a “buy” rating and a $6.00 price target for the company.

Insiders Place Their Bets

In related news, CEO Brady Patrick Priest sold 75,000 shares of the stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $3.68, for a total transaction of $276,000.00. Following the transaction, the chief executive officer now owns 2,418,151 shares of the company’s stock, valued at approximately $8,898,795.68. This represents a 3.01 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Carladenise Armbrister Edwards sold 200,000 shares of the firm’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $3.61, for a total value of $722,000.00. Following the transaction, the director now owns 273,227 shares of the company’s stock, valued at $986,349.47. This trade represents a 42.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 327,500 shares of company stock valued at $1,197,500 over the last 90 days. 22.28% of the stock is owned by company insiders.

Clover Health Investments Trading Up 0.3 %

NASDAQ CLOV opened at $3.68 on Friday. The stock has a market cap of $1.88 billion, a PE ratio of -18.40 and a beta of 1.98. Clover Health Investments, Corp. has a twelve month low of $0.61 and a twelve month high of $4.87. The stock has a fifty day simple moving average of $3.89 and a 200-day simple moving average of $3.74.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.